drugset / Trial / NCT00208221

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

NCT00208221

Phase 3 Terminated 50 enrolled Montreal Clinical Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if a dose of ramipril combined with a normal dose of telmisartan 80 mg will be more effective than ramipril 20 mg in reducing microalbuminuria in hypertensive patients with diabetes.

Timeline

Start
2006-08
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramipril Small molecule 10 mg
Subject Ramipril Small molecule 20 mg
Subject Telmisartan Other / unclassified 80 mg